Jacobs Levy Equity Management’s Guardant Health GH Stock Holding History

Jacobs Levy Equity Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.01M	Buy	33,424 +16,067	+93%	+$1.75M	0.02%	430
2026 Q1	$1.6M	Hold	17,357	–	–	0.01%	623
2025 Q4	$1.77M	Sell	17,357 -787	-4%	-$70.4K	0.01%	603
2025 Q3	$1.13M	Sell	18,144 -646	-3%	-$35.1K	﹤0.01%	693
2025 Q2	$978K	Buy	+18,790	New	+$839K	﹤0.01%	761
2023 Q3	–	Sell	-495,716	Closed	-$17.7M	–	1000
2023 Q2	$17.7M	Sell	495,716 -368,738	-43%	-$10.6M	0.1%	208
2023 Q1	$20.3M	Buy	+864,454	New	+$24.7M	0.12%	187

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jacobs Levy Equity Management's GH Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Guardant Health (GH) stake by 93% in Q2 2026, buying an estimated $1.75M and bringing the position to 33,424 shares worth $5.01M. The position accounts for 0.02% of the portfolio, ranked #430.

Jacobs Levy Equity Management first reported a position in GH in Q1 2023 and has held it in 7 quarters since. The position peaked at $20.3M in Q1 2023. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Jacobs Levy Equity Management held 33,424 shares of Guardant Health worth $5.01M as of Q2 2026.
Jacobs Levy Equity Management bought 16,067 Guardant Health shares in Q2 2026, an estimated $1.75M.
Guardant Health made up 0.02% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #430 holding.
Jacobs Levy Equity Management first reported a position in Guardant Health in Q1 2023 and has held it in 7 quarters since.
Jacobs Levy Equity Management's Guardant Health position peaked at $20.3M in Q1 2023.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.